T. Maji et al. / Journal of Molecular Catalysis A: Chemical 424 (2016) 145–152
147
Table 1
Isomerizing hydroformylation of pent-3-enal.
Entry
CO/H2 (bar)
Temp. (◦C)
Conv. (%)b
%8 formed
1
2
3
4
5
6
7
6
10
20
37
20
20
20
80
80
80
80
70
85(5)
85(5)
85(5)
100
85(5)
100
7.75
6.92
6.59
8.52
4.07
2.74
2.78
90
110
100
aReaction conditions: pent-3-enal (19.5 mmol) in toluene, Rh(acac)(CO)2 (0.056 mmol), DIOP (0.11 mmol), syngas (CO:H2) = 1:1.
berror is due to slight overlap of GC peaks for 3 and n-pentanal.
slowly released into a gas outlet valve inside a fumehood to avoid
exposure to toxic CO. An aliquot was removed for immediate GC
analysis and the product concentrations were determined from
comparison to calibration curves. Pent-3-enal was produced by
similar treatment of 15 g of butadiene solution (20 wt.% in toluene)
with Rh(acac)(CO)2 (14.33 mg, 0.056 mmol) and diphenylphosphi-
noethane (dppe, 22.12 mg, 0.056 mmol) for 4 h and purified by
distillation at 150–160 ◦C. The colorless solution obtained by this
from the calibration curve. The solution can be stored under argon
at low temperature (–20 ◦C) for 2-3 days. A 5.5 g solution of pent-3-
enal in toluene (19.52 mmol) was then treated with Rh(acac)(CO)2
(14.33 mg, 0.056 mmol), DIOP (55.17 mg, 0.11 mmol) at various
temperatures and pressures outlined in Table 1. After 3 h, an aliquot
(150 mg) was removed from the reaction mixture and added to a
10 mL volumetric flask followed by 30 mg of decane and diluted to
10 mL with toluene. The sample was then analyzed by GC and the
product concentrations were calculated from comparison to cal-
ibration curves. Gas chromatographic analysis was performed on
Shimadzu QP2010 SE gas chromatograph equipped with a mass
selective detector (GC–MS) using helium as carrier gas. A SHRXI-
5MS (30 m, 0.25 mm ID, 0.25 um df) capillary column was used. The
He flow rate was kept at 0.92 mL/min. The column temperature was
initially held at 60 ◦C for 2 min, then ramped at 10 ◦C/min to 200 ◦C
and held at this temperature for 5 min. Retention times (min) of the
selected products are as follows: 1,3-butadiene (1.62), trans-pent-
2-enal (2.71), trans-pent-3-enal (2.52), pent-4-enal (2.43), pentanal
(2.55), 2-methylpentanedial (5.87), adipaldehyde (6.95).
(6) (Scheme 3). Hydroformylation of 1,3-butadiene can, in principal,
produce a number of products including the desired adipaldehyde
[17], but the catalytic (DIOP)Rh system only generated few of them
(viz. 3, 4, 6 in Scheme 3). This minimal number of byproducts
adds to our belief that proper mechanistic investigation followed
by rational DIOP/condition modification can increase the selectiv-
ity for adipaldehyde (8). Additionally, the factors providing 32%
selectivity of adipaldehyde by DIOP ligand are still unclear, and a
detailed mechanistic study of 1,3-butadiene hydroformylation by
the (DIOP)Rh catalyst is lacking.
The commonly accepted mechanism for 1,3-butadiene hydro-
and experimental investigations. The observed product distribu-
tion suggests that the first hydroformylation of 1,3-butadiene takes
place by the incorporation of active catalyst Rh-H via the 1,2-
and 1,4-addition pathways (Scheme 3). The 1,2-addition pathway
yields pent-4-enal (7) via intermediate 2, which is analogous to
the hydroformylation of non-conjugated/isolated terminal olefins.
(DIOP)Rh catalyst by us, and (bisphosphite)Rh by others [17,18],
supports the linear hydroformylation preference to adipaldehyde
(Scheme 4). Alternatively, the 1,4-addition of Rh-H proceeds via a
stable 3-crotyl complex (1, Scheme 3) and results in pent-3-enal
Additionally, pentanal (6) formation can be rationalized by direct
hydrogenation of 3 or 7 or via the double bond isomerization of
pent-3-enal (3) to the conjugated pent-2-enal followed by rapid
hydrogenation by the (DIOP)Rh catalyst [28,29].
Finally, we hypothesizedthat pent-3-enal (3) could also undergo
double bond isomerization to the non-conjugated pent-4-enal (7),
which is then rapidly hydroformylated to adipaldehyde (Scheme 2).
There is currently no reported evidence in the literature for this
in situ isomerization-hydroformylation of pent-3-enal (3) to adi-
paldehyde (8) with phosphine-ligated rhodium catalysts. This
prompted us to investigate the possibility of the isomerization-
hydroformylation of pent-3-enal to adipaldehyde, which we now
discuss.
3. Results and discussion
We started our experimental findings by establishing the bench-
mark hydroformylation reaction of 1,3-butadiene with (DIOP)Rh
catalyst as reported by Ohgomori [16]. A toluene solution of buta-
diene, Rh(acac)(CO)2, and DIOP ligand were exposed to syn-gas
(CO/H2 = 1:1) in a parallel Parr reactor at elevated tempera-
ture for several hours. The optimized conditions 18.51 mmol
of 1,3-butadiene in 5 mL toluene, Rh(acac)(CO)2 (0.1 mol%, DIOP
(0.5 mol%), 80 ◦C, syn-gas (20 bar), 3 h) resulted in the full con-
sumption of 1,3-butadiene with 32% selectivity to adipaldehyde,
together with some undesired side products. The major side prod-
ucts were pent-3-enal (3) and the hydrogenation product pentanal